Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.889159977795273e-06,inf,inf,"['RPS26', 'RPS25', 'RPS15A', 'RPS27', 'RPL36A', 'RPL35A', 'RPL26', 'FAU', 'RPL10A', 'RPS27A', 'RPS13', 'RPS23']",0.001522930636580472,0,0,12
2,Hepatitis B infection WP4666,0.060627823880363634,inf,inf,"['TGFB1', 'ATP6AP1', 'CYCS']",0.633674116501348,0,0,3
3,Myometrial relaxation and contraction pathways WP289,0.08137349223853023,6.317757009345795,15.849393065946428,"['IGFBP5', 'RGS16', 'PRKCD', 'CRH']",0.633674116501348,0,0,4
4,MAPK Signaling Pathway WP382,0.08877620734357398,3.9622641509433962,9.595163887605535,"['DUSP4', 'TGFB1', 'DDIT3', 'PRKCD', 'FGF1']",0.633674116501348,0,0,5
5,Acute viral myocarditis WP4298,0.15518530489602064,inf,inf,"['TGFB1', 'CYCS']",0.633674116501348,0,0,2
6,Sleep regulation WP3591,0.15518530489602064,inf,inf,"['CRH', 'HCRTR2']",0.633674116501348,0,0,2
7,AGE/RAGE pathway WP2324,0.15518530489602064,inf,inf,"['PRKCD', 'CYCS']",0.633674116501348,0,0,2
8,Synaptic Vesicle Pathway WP2267,0.15518530489602064,inf,inf,"['SLC32A1', 'CPLX3']",0.633674116501348,0,0,2
9,T-cell receptor (TCR) signaling pathway WP69,0.15518530489602064,inf,inf,"['TGFB1', 'PRKCD']",0.633674116501348,0,0,2
10,Lung fibrosis WP3624,0.15518530489602064,inf,inf,"['TGFB1', 'FGF1']",0.633674116501348,0,0,2
11,Type II interferon signaling (IFNG) WP619,0.15518530489602064,inf,inf,"['PRKCD', 'HLA-B']",0.633674116501348,0,0,2
12,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.15518530489602064,inf,inf,"['TGFB1', 'VIP']",0.633674116501348,0,0,2
13,White fat cell differentiation WP4149,0.15518530489602064,inf,inf,"['DDIT3', 'NR2F2']",0.633674116501348,0,0,2
14,Differentiation Pathway WP2848,0.15518530489602064,inf,inf,"['TGFB1', 'FGF1']",0.633674116501348,0,0,2
15,Parkinson's disease pathway WP2371,0.15518530489602064,inf,inf,"['CYCS', 'UBE2L6']",0.633674116501348,0,0,2
16,Nonalcoholic fatty liver disease WP4396,0.1698847568357478,3.1401869158878504,5.566405148158988,"['TGFB1', 'NDUFB11', 'DDIT3', 'CYCS']",0.633674116501348,0,0,4
17,"GPCRs, Class A Rhodopsin-like WP455",0.1698847568357478,3.1401869158878504,5.566405148158988,"['P2RY14', 'HTR5A', 'MCHR1', 'HCRTR2']",0.633674116501348,0,0,4
18,Corticotropin-releasing hormone signaling pathway WP2355,0.17185175799608565,4.694444444444445,8.267494298854253,"['TGFB1', 'PRKCD', 'CRH']",0.633674116501348,0,0,3
19,Circadian rhythm related genes WP3594,0.30756912253475166,2.3333333333333335,2.7511293326203545,"['CRH', 'RPS27A', 'HCRTR2']",0.633674116501348,0,0,3
20,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3185320743349917,1.561904761904762,1.7868691920900166,"['TRPC3', 'PRKCD', 'CYCS', 'DNAJB9', 'RPL26', 'RPL10A']",0.633674116501348,0,0,6
21,IL-6 signaling pathway WP364,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['PRKCD', 'VIP']",0.633674116501348,0,0,2
22,Integrated breast cancer pathway WP1984,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['FAU', 'JAKMIP1']",0.633674116501348,0,0,2
23,Calcium Regulation in the Cardiac Cell WP536,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['RGS16', 'PRKCD']",0.633674116501348,0,0,2
24,Ectoderm Differentiation WP2858,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['NR2F2', 'JAKMIP1']",0.633674116501348,0,0,2
25,Pancreatic adenocarcinoma pathway WP4263,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['TGFB1', 'PRKCD']",0.633674116501348,0,0,2
26,Photodynamic therapy-induced unfolded protein response WP3613,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['DDIT3', 'DNAJB9']",0.633674116501348,0,0,2
27,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.34430014143328674,3.1009174311926606,3.3063268465524422,"['IFITM3', 'DDIT3']",0.633674116501348,0,0,2
28,Selective expression of chemokine receptors during T-cell polarization WP4494,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
29,IL-3 signaling pathway WP286,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
30,Serotonin and anxiety WP3947,0.39501763106577537,inf,inf,['CRH'],0.633674116501348,0,0,1
31,3q29 copy number variation syndrome WP4906,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
32,Serotonin and anxiety-related events WP3944,0.39501763106577537,inf,inf,['CRH'],0.633674116501348,0,0,1
33,7q11.23 copy number variation syndrome WP4932,0.39501763106577537,inf,inf,['UBE2L6'],0.633674116501348,0,0,1
34,ACE Inhibitor Pathway WP554,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
35,Signal transduction through IL1R WP4496,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
36,Alpha 6 Beta 4 signaling pathway WP244,0.39501763106577537,inf,inf,['PRKCD'],0.633674116501348,0,0,1
37,Alzheimer's disease WP2059,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
38,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
39,Interleukin-11 Signaling Pathway WP2332,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
40,Apoptosis Modulation and Signaling WP1772,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
41,Apoptosis Modulation by HSP70 WP384,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
42,Apoptosis WP254,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
43,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.39501763106577537,inf,inf,['SST'],0.633674116501348,0,0,1
44,ATM Signaling Network in Development and Disease  WP3878,0.39501763106577537,inf,inf,['DCLRE1C'],0.633674116501348,0,0,1
45,B Cell Receptor Signaling Pathway WP23,0.39501763106577537,inf,inf,['PRKCD'],0.633674116501348,0,0,1
46,BDNF-TrkB Signaling WP3676,0.39501763106577537,inf,inf,['TRPC3'],0.633674116501348,0,0,1
47,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
48,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
49,TGF-beta Receptor Signaling WP560,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
50,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
51,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.39501763106577537,inf,inf,['SST'],0.633674116501348,0,0,1
52,Canonical and non-canonical TGF-B signaling WP3874,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
53,Cardiac Hypertrophic Response WP2795,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
54,Metabolic reprogramming in colon cancer WP4290,0.39501763106577537,inf,inf,['PGAM1'],0.633674116501348,0,0,1
55,Transcriptional cascade regulating adipogenesis WP4211,0.39501763106577537,inf,inf,['DDIT3'],0.633674116501348,0,0,1
56,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.39501763106577537,inf,inf,['PRKCD'],0.633674116501348,0,0,1
57,Type 2 papillary renal cell carcinoma WP4241,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
58,Type II diabetes mellitus WP1584,0.39501763106577537,inf,inf,['PRKCD'],0.633674116501348,0,0,1
59,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
60,Mitochondrial CIV Assembly WP4922,0.39501763106577537,inf,inf,['COX14'],0.633674116501348,0,0,1
61,Mitochondrial complex I assembly model OXPHOS system WP4324,0.39501763106577537,inf,inf,['NDUFB11'],0.633674116501348,0,0,1
62,Cori Cycle WP1946,0.39501763106577537,inf,inf,['PGAM1'],0.633674116501348,0,0,1
63,Monoamine GPCRs WP58,0.39501763106577537,inf,inf,['HTR5A'],0.633674116501348,0,0,1
64,MTHFR deficiency WP4288,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
65,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.39501763106577537,inf,inf,['RPH3AL'],0.633674116501348,0,0,1
66,Nanomaterial induced apoptosis WP2507,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
67,DNA IR-double strand breaks and cellular response via ATM WP3959,0.39501763106577537,inf,inf,['DCLRE1C'],0.633674116501348,0,0,1
68,Neovascularisation processes WP4331,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
69,Dopaminergic Neurogenesis WP2855,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
70,NO/cGMP/PKG mediated Neuroprotection WP4008,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
71,Non-homologous end joining WP438,0.39501763106577537,inf,inf,['DCLRE1C'],0.633674116501348,0,0,1
72,NRF2 pathway WP2884,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
73,Nuclear receptors WP170,0.39501763106577537,inf,inf,['NR2F2'],0.633674116501348,0,0,1
74,ESC Pluripotency Pathways WP3931,0.39501763106577537,inf,inf,['FGF1'],0.633674116501348,0,0,1
75,EV release from cardiac cells and their functional effects WP3297,0.39501763106577537,inf,inf,['RGS16'],0.633674116501348,0,0,1
76,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
77,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.39501763106577537,inf,inf,['IGFBP5'],0.633674116501348,0,0,1
78,Fas ligand pathway and stress induction of heat shock proteins WP314,0.39501763106577537,inf,inf,['CYCS'],0.633674116501348,0,0,1
79,Oxidative phosphorylation WP623,0.39501763106577537,inf,inf,['ATP6AP1'],0.633674116501348,0,0,1
80,p38 MAPK Signaling Pathway WP400,0.39501763106577537,inf,inf,['DDIT3'],0.633674116501348,0,0,1
81,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.39501763106577537,inf,inf,['UBE2L6'],0.633674116501348,0,0,1
82,Pathways in clear cell renal cell carcinoma WP4018,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
83,GABA receptor Signaling WP4159,0.39501763106577537,inf,inf,['SLC32A1'],0.633674116501348,0,0,1
84,Galanin receptor pathway WP4970,0.39501763106577537,inf,inf,['PRKCD'],0.633674116501348,0,0,1
85,Gastric acid production WP2596,0.39501763106577537,inf,inf,['VIP'],0.633674116501348,0,0,1
86,PKC-gamma calcium signaling pathway in ataxia WP4760,0.39501763106577537,inf,inf,['TRPC3'],0.633674116501348,0,0,1
87,Platelet-mediated interactions with vascular and circulating cells WP4462,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
88,Pre-implantation embryo WP3527,0.39501763106577537,inf,inf,['DDIT3'],0.633674116501348,0,0,1
89,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
90,Glycogen Synthesis and Degradation WP500,0.39501763106577537,inf,inf,['PHKG1'],0.633674116501348,0,0,1
91,Glycolysis and Gluconeogenesis WP534,0.39501763106577537,inf,inf,['PGAM1'],0.633674116501348,0,0,1
92,Purinergic signaling WP4900,0.39501763106577537,inf,inf,['P2RY14'],0.633674116501348,0,0,1
93,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.39501763106577537,inf,inf,['FGF1'],0.633674116501348,0,0,1
94,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
95,Hepatitis C and Hepatocellular Carcinoma WP3646,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
96,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.39501763106577537,inf,inf,['TGFB1'],0.633674116501348,0,0,1
97,Selenium Micronutrient Network WP15,0.5167483914476043,1.5412844036697249,1.01755471987195,"['SELENOM', 'SELENOH']",0.7638034792729492,0,0,2
98,Adipogenesis WP236,0.5167483914476043,1.5412844036697249,1.01755471987195,"['TGFB1', 'DDIT3']",0.7638034792729492,0,0,2
99,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5167483914476043,1.5412844036697249,1.01755471987195,"['TGFB1', 'CYCS']",0.7638034792729492,0,0,2
100,Endoderm differentiation WP2853,0.5167483914476043,1.5412844036697249,1.01755471987195,"['DUSP4', 'TGFB1']",0.7638034792729492,0,0,2
101,Osteoblast differentiation WP4787,0.5167483914476043,1.5412844036697249,1.01755471987195,"['PRKCD', 'FGF1']",0.7638034792729492,0,0,2
102,Spinal Cord Injury WP2431,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
103,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
104,Aryl Hydrocarbon Receptor Pathway WP2873,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
105,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
106,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
107,MECP2 and Associated Rett Syndrome WP3584,0.6348496451099838,1.5363636363636364,0.6980730707654321,['SST'],0.7638034792729492,0,0,1
108,Cardiac Progenitor Differentiation WP2406,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
109,Cell cycle WP179,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
110,Chemokine signaling pathway WP3929,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
111,Ciliary landscape WP4352,0.6348496451099838,1.5363636363636364,0.6980730707654321,['COPS7A'],0.7638034792729492,0,0,1
112,Unfolded protein response WP4925,0.6348496451099838,1.5363636363636364,0.6980730707654321,['DDIT3'],0.7638034792729492,0,0,1
113,miRNA regulation of DNA damage response WP1530,0.6348496451099838,1.5363636363636364,0.6980730707654321,['CYCS'],0.7638034792729492,0,0,1
114,Cytokines and Inflammatory Response WP530,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
115,DNA damage response WP707,0.6348496451099838,1.5363636363636364,0.6980730707654321,['CYCS'],0.7638034792729492,0,0,1
116,DNA Repair Pathways Full Network WP4946,0.6348496451099838,1.5363636363636364,0.6980730707654321,['DCLRE1C'],0.7638034792729492,0,0,1
117,EGF/EGFR signaling pathway WP437,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
118,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
119,Non-small cell lung cancer WP4255,0.6348496451099838,1.5363636363636364,0.6980730707654321,['CYCS'],0.7638034792729492,0,0,1
120,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6348496451099838,1.5363636363636364,0.6980730707654321,['DDIT3'],0.7638034792729492,0,0,1
121,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
122,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6348496451099838,1.5363636363636364,0.6980730707654321,['TGFB1'],0.7638034792729492,0,0,1
123,Oxidative Damage WP3941,0.6348496451099838,1.5363636363636364,0.6980730707654321,['CYCS'],0.7638034792729492,0,0,1
124,Peptide GPCRs WP24,0.6348496451099838,1.5363636363636364,0.6980730707654321,['HCRTR2'],0.7638034792729492,0,0,1
125,Gastrin signaling pathway WP4659,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
126,Genotoxicity pathway WP4286,0.6348496451099838,1.5363636363636364,0.6980730707654321,['RPS27'],0.7638034792729492,0,0,1
127,Glioblastoma signaling pathways WP2261,0.6348496451099838,1.5363636363636364,0.6980730707654321,['PRKCD'],0.7638034792729492,0,0,1
128,Regulation of Actin Cytoskeleton WP51,0.6348496451099838,1.5363636363636364,0.6980730707654321,['FGF1'],0.7638034792729492,0,0,1
129,Senescence and Autophagy in Cancer WP615,0.6562011023541594,1.0214067278287462,0.4303063756451467,"['TGFB1', 'IGFBP5']",0.7833718586243452,0,0,2
130,IL-18 signaling pathway WP4754,0.6770475950309864,0.9166666666666666,0.35751256354799543,"['RGS16', 'PRKCD', 'CYCS']",0.8020409971905532,0,0,3
131,Allograft Rejection WP2328,0.7616748061925972,0.7614678899082569,0.207298651070405,"['TGFB1', 'HLA-B']",0.8520505023931204,0,0,2
132,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7801241612820128,0.7636363636363637,0.1896125820927056,['TGFB1'],0.8520505023931204,0,0,1
133,Small cell lung cancer WP4658,0.7801241612820128,0.7636363636363637,0.1896125820927056,['CYCS'],0.8520505023931204,0,0,1
134,Male infertility WP4673,0.7801241612820128,0.7636363636363637,0.1896125820927056,['TEX15'],0.8520505023931204,0,0,1
135,TGF-beta Signaling Pathway WP366,0.7801241612820128,0.7636363636363637,0.1896125820927056,['TGFB1'],0.8520505023931204,0,0,1
136,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7801241612820128,0.7636363636363637,0.1896125820927056,['TGFB1'],0.8520505023931204,0,0,1
137,Ciliopathies WP4803,0.7801241612820128,0.7636363636363637,0.1896125820927056,['CCDC65'],0.8520505023931204,0,0,1
138,DNA damage response (only ATM dependent) WP710,0.7801241612820128,0.7636363636363637,0.1896125820927056,['TGFB1'],0.8520505023931204,0,0,1
139,Endometrial cancer WP4155,0.7801241612820128,0.7636363636363637,0.1896125820927056,['FGF1'],0.8520505023931204,0,0,1
140,G Protein Signaling Pathways WP35,0.7801241612820128,0.7636363636363637,0.1896125820927056,['PRKCD'],0.8520505023931204,0,0,1
141,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7801241612820128,0.7636363636363637,0.1896125820927056,['ANGPTL1'],0.8520505023931204,0,0,1
142,Insulin Signaling WP481,0.8679158791141984,0.5060606060606061,0.07168878961922587,['PRKCD'],0.8970405730442051,0,0,1
143,Breast cancer pathway WP4262,0.8679158791141984,0.5060606060606061,0.07168878961922587,['FGF1'],0.8970405730442051,0,0,1
144,Wnt signaling pathway and pluripotency WP399,0.8679158791141984,0.5060606060606061,0.07168878961922587,['PRKCD'],0.8970405730442051,0,0,1
145,Ebola Virus Pathway on Host WP4217,0.8679158791141984,0.5060606060606061,0.07168878961922587,['HLA-B'],0.8970405730442051,0,0,1
146,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8679158791141984,0.5060606060606061,0.07168878961922587,['TGFB1'],0.8970405730442051,0,0,1
147,Endochondral Ossification WP474,0.8679158791141984,0.5060606060606061,0.07168878961922587,['TGFB1'],0.8970405730442051,0,0,1
148,Pathways Regulating Hippo Signaling WP4540,0.8679158791141984,0.5060606060606061,0.07168878961922587,['PRKCD'],0.8970405730442051,0,0,1
149,Proteasome Degradation WP183,0.8679158791141984,0.5060606060606061,0.07168878961922587,['HLA-B'],0.8970405730442051,0,0,1
150,Nuclear Receptors Meta-Pathway WP2882,0.9208443859563586,0.37727272727272726,0.03111150082255563,['TGFB1'],0.9329607594557844,0,0,1
151,Oncostatin M Signaling Pathway WP2374,0.9208443859563586,0.37727272727272726,0.03111150082255563,['PRKCD'],0.9329607594557844,0,0,1
152,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9208443859563586,0.37727272727272726,0.03111150082255563,['FGF1'],0.9329607594557844,0,0,1
153,Vitamin D Receptor Pathway WP2877,0.9286034121236735,0.4272608125819135,0.031648716157768216,"['TGFB1', 'IGFBP5']",0.934672715470887,0,0,2
154,PI3K-Akt signaling pathway WP4172,0.95267813094831,0.3,0.014543452604184246,['FGF1'],0.95267813094831,0,0,1
